![](/img/cover-not-exists.png)
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma
Awan, Farrukh T., Flynn, Joseph M., Jones, Jeffrey A., Andritsos, Leslie A., Maddocks, Kami J., Sass, Ellen J., Lucas, Margaret S., Chase, Weihong, Waymer, Sharon, Ling, Yonghua, Jiang, Yao, Phelps, MLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1014368
Date:
March, 2015
File:
PDF, 961 KB
english, 2015